|
E2F7 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45899975329189E-11 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2467028237827E-11 |
| Normal-vs-Stage2 |
3.212400E-04 |
| Normal-vs-Stage3 |
1.49829999518403E-08 |
| Normal-vs-Stage4 |
1.22530000001841E-06 |
| Stage1-vs-Stage2 |
1.126320E-02 |
| Stage1-vs-Stage3 |
5.879200E-01 |
| Stage1-vs-Stage4 |
4.445200E-01 |
| Stage2-vs-Stage3 |
1.886310E-02 |
| Stage2-vs-Stage4 |
1.889230E-01 |
| Stage3-vs-Stage4 |
2.765200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08559827793897E-11 |
| Normal-vs-AfricanAmerican |
5.84969999999352E-05 |
| Normal-vs-Asian |
1.43220000303756E-08 |
| Caucasian-vs-AfricanAmerican |
8.232400E-01 |
| Caucasian-vs-Asian |
6.167600E-01 |
| AfricanAmerican-vs-Asian |
5.877400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63770000286101E-08 |
| Normal-vs-Female |
4.00329769334462E-11 |
| Male-vs-Female |
6.668600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.96467319979865E-12 |
| Normal-vs-Age(41-60Yrs) |
3.0801999950647E-08 |
| Normal-vs-Age(61-80Yrs) |
5.39179999980988E-07 |
| Normal-vs-Age(81-100Yrs) |
6.46810000000109E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.773600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.988180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.570400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.396200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.457040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.747400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.295400E-01 |
| Classical-VS-Follicular |
6.438100E-04 |
| Classical-VS-Other |
4.596600E-01 |
| Classical-VS-Normal |
4.09283718028064E-12 |
| Tall-VS-Follicular |
2.397800E-02 |
| Tall-VS-Other |
9.889800E-01 |
| Tall-VS-Normal |
1.550900E-04 |
| Follicular-VS-Other |
4.846500E-02 |
| Follicular-VS-Normal |
2.786800E-04 |
| Other-VS-Normal |
2.896100E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09249995108962E-09 |
| Normal-vs-N1 |
1.5715000001304E-07 |
| N0-vs-N1 |
5.612200E-01 |
|
|
